Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 270,170 | 271,513 | 298,932 | 333,395 | 341,016 |
| Receivables | 134,853 | 148,474 | 81,464 | 75,933 | 73,331 |
| Inventories | 70,732 | 74,002 | 81,160 | 96,674 | 88,200 |
| TOTAL | $489,166 | $510,218 | $479,995 | $528,047 | $528,160 |
| Non-Current Assets | |||||
| PPE Net | 381,102 | 376,448 | 362,544 | 359,034 | 342,083 |
| Intangibles | 73,312 | 74,866 | 76,420 | 107,547 | 109,912 |
| Other Non-Current Assets | 8,059 | 8,579 | 13,067 | 61,838 | 55,742 |
| TOTAL | $462,473 | $459,893 | $452,031 | $528,419 | $507,737 |
| Total Assets | $951,639 | $970,111 | $932,026 | $1,056,466 | $1,035,897 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 27,179 | 34,649 | 46,342 | 58,974 | 45,611 |
| Accrued Expenses | 27,664 | 40,905 | 36,381 | 32,260 | 30,715 |
| Other current liabilities | 2,216 | 3,266 | 2,759 | 5,495 | 4,540 |
| TOTAL | $67,706 | $105,856 | $110,306 | $103,858 | $90,455 |
| Non-Current Liabilities | |||||
| Long Term Debt | 248,394 | 248,094 | 247,793 | 247,393 | 247,192 |
| Deferred Revenues | 10,647 | 7,036 | 4,824 | 7,129 | 9,589 |
| Other Non-Current Liabilities | 11,233 | 11,523 | 21,609 | 24,133 | 24,451 |
| TOTAL | $273,514 | $268,050 | $274,097 | $279,936 | $278,460 |
| Total Liabilities | $341,220 | $373,906 | $384,403 | $383,794 | $368,915 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,974 | 40,688 | 40,498 | 40,459 | 40,061 |
| Common Shares | 41 | 41 | 41 | 41 | 40 |
| Retained earnings | 264,965 | 254,480 | 214,686 | 344,184 | 355,130 |
| Other shareholders' equity | -3,248 | -4,751 | -3,992 | -3,500 | -4,572 |
| TOTAL | $610,419 | $596,205 | $547,623 | $672,672 | $666,982 |
| Total Liabilities And Equity | $951,639 | $970,111 | $932,026 | $1,056,466 | $1,035,897 |